UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Kinase Fusion Gene:CPSF6_CDK13 |
Kinase Fusion Protein Summary |
![]() |
Kinase Fusion partner gene information | Kinase Fusion gene name: CPSF6_CDK13 | KinaseFusionDB ID: KFG1426 | FusionGDB2.0 ID: KFG1426 | Hgene | Tgene | Gene symbol | CPSF6 | CDK13 | Gene ID | 11052 | 8621 | |
Gene name | cleavage and polyadenylation specific factor 6 | cyclin dependent kinase 13 | ||||||||||
Synonyms | CFIM|CFIM68|CFIM72|HPBRII-4|HPBRII-7 | CDC2L|CDC2L5|CHDFIDD|CHED|hCDK13 | ||||||||||
Cytomap | 12q15 | 7p14.1 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | cleavage and polyadenylation specificity factor subunit 6CPSF 68 kDa subunitcleavage and polyadenylation specific factor 6, 68kDacleavage and polyadenylation specificity factor 68 kDa subunitcleavage factor Im complex 68 kDa subunitpre-mRNA cleavage | cyclin-dependent kinase 13CDC2-related protein kinase 5cell division cycle 2-like protein kinase 5cell division protein kinase 13cholinesterase-related cell division controller | ||||||||||
Modification date | 20240411 | 20240407 | ||||||||||
UniProtAcc | Q16630 | Q14004 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000266679, ENST00000435070, ENST00000456847, ENST00000551516, ENST00000550987, | ENST00000181839, ENST00000340829, ENST00000484589, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: CPSF6 [Title/Abstract] AND CDK13 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CPSF6(69656342)-CDK13(40027198), # samples:1 |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CPSF6 | GO:0006397 | mRNA processing | 14690600 |
Hgene | CPSF6 | GO:0031124 | mRNA 3'-end processing | 20695905 |
Hgene | CPSF6 | GO:0051179 | localization | 30916345 |
Hgene | CPSF6 | GO:0051262 | protein tetramerization | 20695905 |
Hgene | CPSF6 | GO:0051290 | protein heterotetramerization | 23187700 |
Tgene | CDK13 | GO:0009966 | regulation of signal transduction | 26748711 |
Tgene | CDK13 | GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 26748711 |
Tgene | CDK13 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20952539 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Kinase Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChimerDB4 | TCGA-D7-8574-01A | CPSF6 | chr12 | 69656342 | CDK13 | chr7 | 40027198 |
Top |
Kinase Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
ENST00000551516 | ENST00000181839 | CPSF6 | chr12 | 69656342 | CDK13 | chr7 | 40027198 | 5654 | 1164 |
Top |
Kinase Fusion Amino Acid Sequences |
![]() |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq >ENST00000551516_ENST00000181839_CPSF6_chr12_69656342_CDK13_chr7_40027198_length(amino acids)=1164 MADGVDHIDIYADVGEEFNQEAEYEREAENERGTGIVTETVTESVTESANIVIVRRRSGKSRSRSPYSSRHSRSRSRHRLSRSRSRHSSI SPSTLTLKSSLAAELNKNKKARAAEAARAAEAAKAAEATKAAEAAAKAAKASNTSTPTKGNTETSASASQTNHVKDVKKIKIEHAPSPSS GGTLKNDKAKTKPPLQVTKVENNLIVDKATKKAVIVGKESKSAATKEESVSLKEKTKPLTPSIGAKEKEQHVALVTSTLPPLPLPPMLPE DKEADSLRGNISVKAVKKEVEKKLRCLLADLPLPPELPGGDDLSKSPEEKKTATQLHSKRRPKICGPRYGETKEKDIDWGKRCVDKFDII GIIGEGTYGQVYKARDKDTGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDL MGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGE ERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYM LALDPSKRCTAEQALQCEFLRDVEPSKMPPPDLPLWQDCHELWSKKRRRQKQMGMTDDVSTIKAPRKDLSLGLDDSRTNTPQGVLPSSQL KSQGSSNVAPVKTGPGQHLNHSELAILLNLLQSKTSVNMADFVQVLNIKVNSETQQQLNKINLPAGILATGEKQTDPSTPQQESSKPLGG IQPSSQTIQPKVETDAAQAAVQSAFAVLLTQLIKAQQSKQKDVLLEERENGSGHEASLQLRPPPEPSTPVSGQDDLIQHQDMRILELTPE PDRPRILPPDQRPPEPPEPPPVTEEDLDYRTENQHVPTTSSSLTDPHAGVKAALLQLLAQHQPQDDPKREGGIDYQAGDTYVSTSDYKDN FGSSSFSSAPYVSNDGLGSSSAPPLERRSFIGNSDIQSLDNYSTASSHSGGPPQPSAFSESFPSSVAGYGDIYLNAGPMLFSGDKDHRFE -------------------------------------------------------------- |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:69656342/chr7:40027198) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CPSF6 | CDK13 |
FUNCTION: Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs (PubMed:9659921, PubMed:8626397, PubMed:14690600, PubMed:29276085). CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals) (PubMed:9659921, PubMed:8626397, PubMed:14690600). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation (PubMed:23187700, PubMed:29276085). The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs (PubMed:20695905, PubMed:29276085). CPSF6 enhances NUDT21/CPSF5 binding to 5'-UGUA-3' elements localized upstream of pA signals and promotes RNA looping, and hence activates directly the mRNA 3'-processing machinery (PubMed:15169763, PubMed:29276085, PubMed:21295486). Plays a role in mRNA export (PubMed:19864460). {ECO:0000269|PubMed:14690600, ECO:0000269|PubMed:15169763, ECO:0000269|PubMed:19864460, ECO:0000269|PubMed:20695905, ECO:0000269|PubMed:21295486, ECO:0000269|PubMed:23187700, ECO:0000269|PubMed:29276085, ECO:0000269|PubMed:8626397, ECO:0000269|PubMed:9659921}.; FUNCTION: (Microbial infection) Binds HIV-1 capsid-nucleocapsid (HIV-1 CA-NC) complexes and might thereby promote the integration of the virus in the nucleus of dividing cells (in vitro). {ECO:0000269|PubMed:24130490}. | FUNCTION: Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. {ECO:0000269|PubMed:16721827, ECO:0000269|PubMed:1731328, ECO:0000269|PubMed:18480452, ECO:0000269|PubMed:20952539}. |
![]() |
![]() |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
![]() |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Tgene | CPSF6 | 69656342 | CDK13 | 40027198 | ENST00000551516 | 0 | 14 | 705_998 | 403 | 1453 | Domain | Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159 |
Tgene | CPSF6 | 69656342 | CDK13 | 40027198 | ENST00000551516 | 0 | 14 | 705_998 | 403 | 1513 | Domain | Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159 |
Top |
Kinase Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Kinase Fusion protein CIF link (fusion AA seq ID in KinaseFusionDB) | Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | AA seq | Len(AA seq) |
PDB file >>>124_CPSF6_CDK13 | ENST00000551516 | ENST00000181839 | CPSF6 | chr12 | 69656342 | CDK13 | chr7 | 40027198 | MADGVDHIDIYADVGEEFNQEAEYEREAENERGTGIVTETVTESVTESANIVIVRRRSGKSRSRSPYSSRHSRSRSRHRLSRSRSRHSSI SPSTLTLKSSLAAELNKNKKARAAEAARAAEAAKAAEATKAAEAAAKAAKASNTSTPTKGNTETSASASQTNHVKDVKKIKIEHAPSPSS GGTLKNDKAKTKPPLQVTKVENNLIVDKATKKAVIVGKESKSAATKEESVSLKEKTKPLTPSIGAKEKEQHVALVTSTLPPLPLPPMLPE DKEADSLRGNISVKAVKKEVEKKLRCLLADLPLPPELPGGDDLSKSPEEKKTATQLHSKRRPKICGPRYGETKEKDIDWGKRCVDKFDII GIIGEGTYGQVYKARDKDTGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDL MGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGE ERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYM LALDPSKRCTAEQALQCEFLRDVEPSKMPPPDLPLWQDCHELWSKKRRRQKQMGMTDDVSTIKAPRKDLSLGLDDSRTNTPQGVLPSSQL KSQGSSNVAPVKTGPGQHLNHSELAILLNLLQSKTSVNMADFVQVLNIKVNSETQQQLNKINLPAGILATGEKQTDPSTPQQESSKPLGG IQPSSQTIQPKVETDAAQAAVQSAFAVLLTQLIKAQQSKQKDVLLEERENGSGHEASLQLRPPPEPSTPVSGQDDLIQHQDMRILELTPE PDRPRILPPDQRPPEPPEPPPVTEEDLDYRTENQHVPTTSSSLTDPHAGVKAALLQLLAQHQPQDDPKREGGIDYQAGDTYVSTSDYKDN FGSSSFSSAPYVSNDGLGSSSAPPLERRSFIGNSDIQSLDNYSTASSHSGGPPQPSAFSESFPSSVAGYGDIYLNAGPMLFSGDKDHRFE | 1164 |
3D view using mol* of 124_CPSF6_CDK13 | ||||||||||
PDB file >>>TKFP_205_CPSF6_CDK13 | ENST00000551516 | ENST00000181839 | CPSF6 | chr12 | 69656342 | CDK13 | chr7 | 40027198 | MADGVDHIDIYADVGEEFNQEAEYEREAENERGTGIVTETVTESVTESANIVIVRRRSGKSRSRSPYSSRHSRSRSRHRLSRSRSRHSSI SPSTLTLKSSLAAELNKNKKARAAEAARAAEAAKAAEATKAAEAAAKAAKASNTSTPTKGNTETSASASQTNHVKDVKKIKIEHAPSPSS GGTLKNDKAKTKPPLQVTKVENNLIVDKATKKAVIVGKESKSAATKEESVSLKEKTKPLTPSIGAKEKEQHVALVTSTLPPLPLPPMLPE DKEADSLRGNISVKAVKKEVEKKLRCLLADLPLPPELPGGDDLSKSPEEKKTATQLHSKRRPKICGPRYGETKEKDIDWGKRCVDKFDII GIIGEGTYGQVYKARDKDTGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDL MGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGE ERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYM LALDPSKRCTAEQALQCEFLRDVEPSKMPPPDLPLWQDCHELWSKKRRRQKQMGMTDDVSTIKAPRKDLSLGLDDSRTNTPQGVLPSSQL KSQGSSNVAPVKTGPGQHLNHSELAILLNLLQSKTSVNMADFVQVLNIKVNSETQQQLNKINLPAGILATGEKQTDPSTPQQESSKPLGG IQPSSQTIQPKVETDAAQAAVQSAFAVLLTQLIKAQQSKQKDVLLEERENGSGHEASLQLRPPPEPSTPVSGQDDLIQHQDMRILELTPE PDRPRILPPDQRPPEPPEPPPVTEEDLDYRTENQHVPTTSSSLTDPHAGVKAALLQLLAQHQPQDDPKREGGIDYQAGDTYVSTSDYKDN FGSSSFSSAPYVSNDGLGSSSAPPLERRSFIGNSDIQSLDNYSTASSHSGGPPQPSAFSESFPSSVAGYGDIYLNAGPMLFSGDKDHRFE | 1164_CPSF6_CDK13 |
Top |
Comparison of Fusion Protein Isoforms |
![]() * Download the pdb file and open it from the molstar online viewer. |
![]() |
Top |
Comparison of Fusion Protein Sequences/Structures with Known Sequences/Structures from PDB |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. * The blue color at the bottom marks the best active site residues. |
124_CPSF6_CDK13.png |
![]() |
124_CPSF6_CDK13.png |
![]() |
Top |
Potential Active Site Information |
![]() |
Kinase Fusion AA seq ID in KinaseFusionDB | Site score | Size | Dscore | Volume | Exposure | Enclosure | Contact | Phobic | Philic | Balance | Don/Acc | Residues |
Top |
Ramachandran Plot of Kinase Fusion Protein Structure |
![]() |
124_CPSF6_CDK13_ramachandran.png |
![]() |
Top |
Virtual Screening Results |
![]() Distribution of the number of occurrence across all approved kinase inhibitors. |
5'-kinase fusion protein case |
3'-kinase fusion protein case |
![]() |
Top |
![]() * The detailed information of individual kinase inhibitors are available in the download page. |
Fusion gene name info | Drug | Docking score | Glide g score | Glide energy |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Netarsudil | -7.03377 | -7.0448699999999995 | -46.3618 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Netarsudil | -7.03377 | -7.0448699999999995 | -46.3618 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Pralsetinib | -6.22895 | -6.32045 | -46.7204 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Cobimetinib | -6.17689 | -6.17969 | -38.8708 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Gilteritinib | -6.175730000000001 | -6.20213 | -43.7845 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Gilteritinib | -6.175730000000001 | -6.20213 | -43.7845 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Pralsetinib | -6.1064300000000005 | -6.19793 | -48.0336 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Lapatinib | -6.07702 | -6.16582 | -50.9228 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Dabrafenib | -6.037999999999999 | -6.454 | -39.2633 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Dabrafenib | -6.037999999999999 | -6.454 | -39.2633 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Pralsetinib | -6.0287 | -6.1202 | -45.9383 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Ruxolitinib | -5.96842 | -5.96842 | -33.8232 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Zanubrutinib | -5.9589300000000005 | -5.9589300000000005 | -29.77 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Pralsetinib | -5.86386 | -5.95536 | -45.1021 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Axitinib | -5.84141 | -5.844609999999999 | -35.8481 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Futibatinib | -5.82965 | -5.82965 | -37.6853 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Cabozantinib | -5.82511 | -5.8701099999999995 | -40.289 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Cabozantinib | -5.82511 | -5.8701099999999995 | -40.289 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Nilotinib | -5.80971 | -6.73451 | -46.1064 |
124_CPSF6_CDK13-DOCK_HTVS_1-001 | Nilotinib | -5.80971 | -6.73451 | -46.1064 |
Top |
Kinase-Substrate Information of CPSF6_CDK13 |
![]() (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
CDK13 | Q14004 | human | SERINC5 | Q86VE9 | S360 | ARCCFCFsPGGEDTE | Serinc |
CDK13 | Q14004 | human | EIF4EBP1 | Q13541 | S65 | FLMECrNsPVtktPP | eIF_4EBP |
CDK13 | Q14004 | human | EIF4B | P23588 | S406 | RPRERHPsWRsEEtQ | |
CDK13 | Q14004 | human | POLR2A | P24928 | S1616 | TPQSPSysPtsPsYS | RNA_pol_Rpb1_R |
CDK13 | Q14004 | human | EIF4EBP1 | Q13541 | T70 | rNsPVtktPPRDLPt | eIF_4EBP |
CDK13 | Q14004 | human | POLR2A | P24928 | S1619 | SPSysPtsPsYSPTS | RNA_pol_Rpb1_R |
CDK13 | Q14004 | human | EIF4EBP1 | Q13541 | T46 | GGtLFsttPGGtRII | eIF_4EBP |
CDK13 | Q14004 | human | EIF4B | P23588 | S422 | RERsRtGsEssQtGt |
![]() (GeneMANIA website) |
![]() |
Kinase | GOID | GO term | P.adjust |
CDK13 | ID | Description | 0.00e+00 |
CDK13 | GO:0006446 | regulation of translational initiation | 5.02e-03 |
CDK13 | GO:0006413 | translational initiation | 5.52e-03 |
CDK13 | GO:0032329 | serine transport | 3.03e-02 |
CDK13 | GO:0006563 | L-serine metabolic process | 3.03e-02 |
CDK13 | GO:0009070 | serine family amino acid biosynthetic process | 3.06e-02 |
CDK13 | GO:0045947 | negative regulation of translational initiation | 3.06e-02 |
CDK13 | GO:0006658 | phosphatidylserine metabolic process | 3.06e-02 |
CDK13 | GO:0006353 | DNA-templated transcription termination | 3.49e-02 |
CDK13 | GO:0009069 | serine family amino acid metabolic process | 4.13e-02 |
CDK13 | GO:0033120 | positive regulation of RNA splicing | 4.28e-02 |
CDK13 | GO:0015804 | neutral amino acid transport | 4.90e-02 |
CDK13 | GO:1901607 | alpha-amino acid biosynthetic process | 5.33e-02 |
CDK13 | GO:0008652 | amino acid biosynthetic process | 5.49e-02 |
CDK13 | GO:0015807 | L-amino acid transport | 5.95e-02 |
CDK13 | GO:0006575 | cellular modified amino acid metabolic process | 6.91e-02 |
CDK13 | GO:0045931 | positive regulation of mitotic cell cycle | 6.91e-02 |
CDK13 | GO:0042552 | myelination | 6.91e-02 |
CDK13 | GO:0007272 | ensheathment of neurons | 6.91e-02 |
CDK13 | GO:0008366 | axon ensheathment | 6.91e-02 |
CDK13 | GO:0006865 | amino acid transport | 6.91e-02 |
CDK13 | GO:0031929 | TOR signaling | 7.32e-02 |
CDK13 | GO:0043484 | regulation of RNA splicing | 7.56e-02 |
CDK13 | GO:1901605 | alpha-amino acid metabolic process | 8.26e-02 |
CDK13 | GO:0000082 | G1/S transition of mitotic cell cycle | 8.63e-02 |
CDK13 | GO:0008654 | phospholipid biosynthetic process | 8.63e-02 |
CDK13 | GO:0044843 | cell cycle G1/S phase transition | 8.63e-02 |
CDK13 | GO:0006520 | amino acid metabolic process | 8.63e-02 |
CDK13 | GO:0006650 | glycerophospholipid metabolic process | 8.63e-02 |
CDK13 | GO:0017148 | negative regulation of translation | 8.63e-02 |
CDK13 | GO:0045787 | positive regulation of cell cycle | 8.63e-02 |
CDK13 | GO:0046394 | carboxylic acid biosynthetic process | 8.63e-02 |
CDK13 | GO:0051607 | defense response to virus | 8.63e-02 |
CDK13 | GO:0140546 | defense response to symbiont | 8.63e-02 |
CDK13 | GO:0016053 | organic acid biosynthetic process | 8.63e-02 |
CDK13 | GO:0034249 | negative regulation of amide metabolic process | 8.63e-02 |
CDK13 | GO:0046942 | carboxylic acid transport | 8.63e-02 |
CDK13 | GO:0015849 | organic acid transport | 8.63e-02 |
CDK13 | GO:0006644 | phospholipid metabolic process | 8.93e-02 |
CDK13 | GO:0046486 | glycerolipid metabolic process | 9.04e-02 |
CDK13 | GO:0051347 | positive regulation of transferase activity | 9.34e-02 |
CDK13 | GO:0009615 | response to virus | 9.50e-02 |
CDK13 | GO:0015711 | organic anion transport | 9.50e-02 |
CDK13 | GO:0044772 | mitotic cell cycle phase transition | 9.75e-02 |
CDK13 | GO:0008380 | RNA splicing | 9.75e-02 |
Top |
Related Drugs to CPSF6_CDK13 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
![]() |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to CPSF6_CDK13 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
![]() |
![]() |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |